Kodiak Sciences
$40.63
71
-$2.18-5.09% Thursday 20:00
Statistics
Day High
42.2
Day Low
38.7
52W High
45.6
52W Low
1.92
Volume
1,641,535
Avg. Volume
1,058,088
Mkt Cap
2.16B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18MayExpected
Expected EPS
-0.793333
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-352.41MNet Income
Analyst Ratings
$43.20Average Price Target
The highest estimate is 80.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 80%
Hold 20%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow KOD. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regenxbio
RGNX
Mkt Cap645.07M
Bausch Health Companies
BHC
Mkt Cap2.62B
Novartis
NVS
Mkt Cap237.61B
Abbvie
ABBV
Mkt Cap385.18B
GSK
GSK
Mkt Cap94.51B
Pfizer
PFE
Mkt Cap140.15B
About
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Show more...
CEO
Dr. Victor Perlroth M.D.
Employees
109
Country
US
ISIN
US50015M1099
Listings
0 Comments
Share your thoughts
FAQ
What is Kodiak Sciences stock price today?▼
The current price of KOD is $40.63 USD — it has decreased by -5.09% in the past 24 hours. Watch Kodiak Sciences stock price performance more closely on the chart.
What is Kodiak Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Kodiak Sciences stocks are traded under the ticker KOD.
Is Kodiak Sciences stock price growing?▼
KOD stock has risen by +9.81% compared to the previous week, the month change is a +53.67% rise, over the last year Kodiak Sciences has showed a +1,592.92% increase.
What is Kodiak Sciences market cap?▼
Today Kodiak Sciences has the market capitalization of 2.16B
When is the next Kodiak Sciences earnings date?▼
Kodiak Sciences is going to release the next earnings report on May 18, 2026.
What were Kodiak Sciences earnings last quarter?▼
KOD earnings for the last quarter are -1.04 USD per share, whereas the estimation was -1.04 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kodiak Sciences revenue for the last year?▼
Kodiak Sciences revenue for the last year amounts to 0 USD.
What is Kodiak Sciences net income for the last year?▼
KOD net income for the last year is -352.41M USD.
How many employees does Kodiak Sciences have?▼
As of April 03, 2026, the company has 109 employees.
In which sector is Kodiak Sciences located?▼
Kodiak Sciences operates in the Health Care sector.
When did Kodiak Sciences complete a stock split?▼
Kodiak Sciences has not had any recent stock splits.
Where is Kodiak Sciences headquartered?▼
Kodiak Sciences is headquartered in Palo Alto, US.